Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE:MTEC) (Frankfurt:3CM) (OTC:CANVF), a leading digital cannabis education and analytics company, is pleased to announce it has signed an agreement to be the exclusive provider of unbiased cannabis education for Liberty Leaf Holdings Ltd. (CSE: LIB) (OTC: LIBFF) (FSE: HN3P) (“Liberty Leaf”), who among other assets, is operating a cannabis accessories e-commerce platform, SignaturebyLibertyLeaf.com. The agreement calls for Cannvas to provide original evidence-based educational content, progressive learning modules and value-added services to the Liberty Leaf platform through white labeling solutions powered by the Cannvas.Me educational platform.
“We are thrilled to partner with Liberty Leaf to ensure their audiences have easy access to a library of unbiased cannabis education powered by the physician-backed and educator-approved Cannvas.Me digital learning platform,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech. “As we work toward our goal of becoming the leading third-party arm’s-length resource for unbiased information and education on cannabis, it’s encouraging to establish partnerships with companies like Liberty Leaf who understand the value of educating consumers and empowering them with the information to make beneficial cannabis choices.”
Under the terms of the agreement, Cannvas will provide subscription-based white-label educational services based on its original educational content, created and curated by its independent Medical, Educational and Cannabis Sciences Advisory Boards. Consideration for the services reflected in the agreement comes in the form of a 12-month paid subscription with an annual sum to be reviewed following each year and with ample room for expansion of services and offerings.
Liberty Leaf is a Canadian-based public company whose objective is to be at the forefront of the cannabis industry, accelerating the expansion of revenue-generating businesses within the rapidly growing sector. Its business strategy places Liberty Leaf’s vertically integrated legal cannabis grower/processor/distributor operations in the middle of an expected multibillion-dollar cannabis boom.
Will Rascan, Liberty Leaf’s President and Director, explained, “One of our mandates at Liberty Leaf is to take a leadership role in contributing to the cannabis community. Providing quality education around cannabis through our various platforms, including our Signature site, is a key way of doing that – and now, partnering with Cannvas MedTech, we can go ahead.”
“All the content we put out through Cannvas will be physician-backed and education-approved. That’s very important to us at Liberty Leaf,” Rascan stresses, “because we feel the community deserves, and it’s important for us to deliver, solid, reliable information.”
Rascan adds, “From a business perspective, providing quality content is not only the right thing to do, but differentiates Liberty Leaf in terms of how our brands are positioned.”
Once fully integrated with the Liberty Leaf platform, its audience will be able to access Cannvas.Me educational content from anywhere in the world, and Cannvas expects to work closely with Liberty Leaf’s partner network to source information and collaborate on articles to meet the needs of the communities it serves across Canada.
About Liberty Leaf Holdings Ltd.
Liberty Leaf is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added cannabidiol products and accessory products within this dynamic and fast-growing sector.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).